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Abstract.  The 289 residue nuclear oncoprotein en- 
coded by the adenovirus 5  Ela gene contains two pep- 
tide sequences that behave as nuclear localization 
signals (NLS).  One signal, located at the carboxy ter- 
minus, is like many other known NLSs in that it con- 
sists of a  short stretch of basic residues (KRPRP) and 
is constitutively active in cells. The second signal re- 
sides within an internal 45  residue region of Ela that 
contains few basic residues or sequences that resemble 
other known NLSs.  Moreover, this internal signal 
functions in injected Xenopus oocytes, but not in 
transfected Xenopus A6 cells, suggesting that it could 
be regulated developmentally (Slavicek et al.  1989. 
J.  Virol. 63:4047).  In this study, we show that the ac- 
tivity of this signal is sensitive to ATP depletion in 
vivo, efficiently directs the import of a  50 kD fusion 
protein and can compete with the Ela carboxy-terminal 
NLS for nuclear import. In addition, we have delineated 
the precise amino acid residues that comprise the sec- 
ond Ela NLS, and have assessed its utilization during 
Xenopus embryogenesis. Using amino acid deletion 
and substitution analyses, we show that the signal con- 
sists of the sequence FV(X)7.20MXSLXYM(X)4ME  By 
expressing in Xenopus  embryos a truncated Ela protein 
that contains only the second NLS and by monitoring 
its cytoplasmic/nuclear distribution during develop- 
ment with indirect immunofluorescence, we find that 
the second NLS is utilized up to the early neurula 
stage. In addition, there appears to be a hierarchy 
among the embryonic germ layers as to when the sec- 
ond NLS becomes nonfunctional. For this reason, we 
refer to this NLS as the developmentally regulated nu- 
clear localization signal (drNLS).  The implications of 
these findings for early development are discussed. 
M 
ost proteins that are selectively transported into the 
cell nucleus contain a discrete peptide sequence 
that  functions  as  a  nuclear  localization  signal 
(NLS) ~. Many NLSs are similar in residue composition to 
the archetypically simple SV-40 large T antigen NLS, which 
consists of the short stretch of basic amino acids, PPKKKRKV 
(22; reviewed in 14, 43, 56). Other NLSs, such as that pres- 
ent in nucleoplasmin, are more complex in character and 
have a bipartite structure with import-requiring basic res- 
idues separated by a spacer region (48). 
While  the  exact  sequence  and  structure  among  NLSs 
varies,  it has been shown that nuclear transport proceeds 
through the nuclear pore complex (2,  12),  that it requires 
ATP hydrolysis (35) and that it occurs as a two-step process; 
the binding of proteins to the pore complex, and the trans- 
port through the central pore complex channel (2, 34). It has 
also been shown that the rate of nuclear import is directly 
related to the number of NLSs present in a protein (11), that 
the kinetics of nuclear import are saturatable (16) and that 
NLSs from different proteins can compete with each other 
for import (16, 66). These data suggest that nuclear transport 
1.  Abbreviations  used  in  this  paper:  drNLS,  developmentally regulated 
NLS; MBP, maltose binding protein; MBS, modified Barth's solution; NLS, 
nuclear localization signal. 
is receptor mediated and, further, that there is a  common 
pathway used by many different proteins for nuclear import. 
Indeed, proteins that can recognize a  variety of NLS se- 
quences have been identified from a number of organisms (1, 
61, 66). 
Although nuclear localization signals often function con- 
stitutively, their activity can also be regulated through the 
phosphorylation of residues residing within or flanking the 
NLS (31, 46, 47), or through distant peptide regions that can 
either"mask" the NLS or anchor the protein in the cytoplasm 
(18, 19, 53). This is the case for a number of proteins includ- 
ing cyclins A and B (41), the transcription factor NF-kB (53), 
and the c-fos protein (50). One particularly dramatic exam- 
ple of regulated nuclear import and its utility in the control 
of gene expression is the Drosophila dorsal protein (49, 51, 
60). Dorsal, the morphogen that determines the dorsoventral 
polarity of the embryo,  is found in the cytoplasm during 
early embryogenesis. During cleavage,  however, dorsal be- 
comes localized to the nucleus only in the ventral portion of 
the embryo, where it appears to activate the transcription of 
the ventralizing genes, twist and snail (24,  62).  The failure 
of regulated nuclear localization in this case results in aber- 
rant development and demonstrates the importance of regu- 
lated nuclear transport in the control of gene expression. 
One example of a  protein with both a  constitutive and 
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clear oncoprotein encoded by the  adenovirus type 5  Ela 
gene. In this protein, the constitutive carboxy-terminal NLS 
is T-antigen NLS-like in composition and consists of the se- 
quence KRPRP (25).  An apparently regulated NLS resides 
within residues 140-185-(59)  and while this region contains 
a  zinc-finger structure important for Ela-mediated transacti- 
vation activity (5, 64), there are few basic residues and no 
similarities to other known nuclear localization signals. This 
region is thought to be regulated because it can direct nuclear 
import  in  injected Xenopus oocytes,  but  not  transfected 
Xenopus A6 cells or Hela cells. 
In this report, we show that nuclear import via the second, 
regulated Ela NLS is ATP dependent and that the signal can 
compete with the Ela carboxy terminus NLS for nuclear im- 
port, demonstrating that the signal directs nuclear import 
using selective import pathways and not through diffuse and 
bind mechanisms (38, 39).  We have also defined the amino 
acid residues that constitute this NLS and have assessed its 
use during early Xenopus development. We find the structure 
of the signal to be complex in that nuclear import requiring 
residues are separated by spacer regions. In addition, this 
signal is very hydrophobic, contains no basic residues and, 
therefore, bears no resemblance to other known NLSs. In 
Xenopus embryos  derived  from  DNA-injected  fertilized 
eggs, we find that this NLS directs nuclear import up until 
the  early  neurula  stage  in  all embryonic tissues.  Subse- 
quently, the use of this NLS is turned off in specific tissues 
at specific times. By the tailbud stage of development, the 
NLS does not function in any tissue. We discuss the implica- 
tion of this finding for the regulated nuclear localization of 
proteins during early development. 
Materials and Methods 
Plasmid Construction 
Plasmid pCE, which contains the genomic copy of the adenovirus type 5 
Ela gene, including the promoter region, has been described (54).  This 
plasmid was digested with XhaI, filled-in and religated to give pCER that 
lacks 66 carboxy-terminal residues,  thus eliminating the COOH terminus 
NLS (59).  Plasmids encoding Ela deletion mutants, pDLlll0, pDLII12, 
pDL1113, and pDL1114 (gifts of S. Bayley, McMaster University) (20) were 
treated as described for pCER to give carboxy-terminal  truncations that lack 
the COOH-terminai NLS. Plasmids pSPEIaX, pSP12S, and pSP12SX have 
been described previously  (59). 
Site Directed Mutagenesis and Synthesis 
of Deletion Mutants 
Oligonucleotide  directed mutagenesis was done essentially  as described 
(57)  except that ssDNA was made from pBSSK- CER,  which was con- 
structed by placing the SacII-SacI fragment of pCER into the SacII-SacI 
sites of pBlueScriptSK- (Stratagene Inc., La Jolla, CA). Constructs were 
confirmed by restriction enzyme digestion and DNA sequencing according 
to Sanger et al. (52). The following oligonucleotides  were used to generate 
mutant sequences (newly inserted restriction sites are noted in bold): pill72 
(NsiI)-  GCGAATGCATAATATCTGG;  pF2-  CATATAGAAAAGCGAA- 
AACATAATATC; pH3 (HindRI)- GTAGACAACd2TIV_~CACAGG; p846 
(EcoRI)-  CCTCATATAGCAGAATTCACACATAATATCTGG; p847  (Eco- 
RI)-  CCACAGGTCC~TTCGCAAAGCGAACAC;  p848  (EcoRI)- 
GC  GAACAGAATTCATC  TGGGTC C C. 
The clone pA20 was produced by first cutting pill71 in the polylinker 
with XhoI and BamHI, filling in with Klenow and religating; this makes the 
Sinai site of the Ela coding region unique.  This clone was cut with Smal 
and NsiI and the adapter oligonucleotidr  ATGCA, was ligated to the NsiI 
5' cut site, filled in with Klenow and religated.  Deletions p4153 and p4157 
were constructed by opening the pill71 clone with Sinai and digesting with 
Bali, filling in with Klenow and religating.  In-frame deletions were deter- 
mined by DNA sequencing.  Clones p4153-NH3  and p4157-NH3 were con- 
structed by replacing the NsiI-SacI fragment of p4153 and p4157 with the 
NsiI-SacI fragment from pCER-H3. 
Oocyte Injection and Immunoprecipitation 
For nuclear transport studies, manually defolliculated stage VI oocytes (10) 
were injected intranuclearly with '~5 nl of DNA (0.1/~g//~l), cultured over- 
night in  lx  MBS (26)  and then placed in  100 uCi/ml  [3SS]methionine 
(New England Nuclear,  Boston, MA) in lx  MBS. Oocytes  were labeled 
for 4 h before germinal vesicles and cytoplasms were manually separaW.d. 
Typically,  20  oocytes  per  construct  were  used.  Cytoplasms  were 
homogenized in Ix  MBS containing 0.02% Triton X-100 and centrifuged 
at 10,000 g for 1 rain. The supernatant was collected and adjusted to lx 
radioimmunoprecipitation assay buffer (RIPA) (50 mM Tris-I-ICl, pH 7.5, 
150 mM NaC1, 1% deoxycholate,  1% Triton X-100, 0.1% SDS). Germinal 
vesicles were directly homogenized in Ix  RIPA buffer. Immunoprecipita- 
tions were done using either monoclonai (M73, Oncogene Sciences,  Inc., 
Manhasset, NY) or rabbit antiserum directed against bacterially expressed 
Ela  protein.  Antibodies  were  diluted  to  1:50  and  incubated  with 
homogenates  for 1-3 h at 40C, which was followed by the addition of 15 
/zl of protein A-Sepharose beads suspended in Ix RIPA. After incubation 
for 1 h at 4~  with constant agitation, the beads were centrifuged, washed 
3 ￿  with RIPA buffer, resuspended in Laemmli sample buffer (23), boiled 
for 5 min and applied to a 12% SDS-polyacrylamide gel. After electropho- 
resis,  gels were fixed, enhanced (EnHance, Amersham Corp.), dried and 
exposed  to x-ray film for 0.5-7  d.  Several exposures  of autoradiographs 
were scanned densitometrically,  areas under appropriate bands were deter- 
mined, and the percent nuclear localization  for each relevant protein was 
determined. The amount nuclear of each mutant protein was standardized 
relative to the amount nuclear of the ElaX protein, which was determined 
empirically in each experiment. 
In vivo  ATP Depletion 
Manually defolliculated stage VI oocytes were injected with 30 ni of apyrase 
(Sigma Type I) at 100 U/ml, incubated for 1 h, then injected with 30 nl of 
rabbit reticulocyte  lysate (Promega Corp., Madison, WI) that were primed 
with either SPElaX or SP12S mRNAs and [35S]methionine. Oocytes were 
held for times indicated in lx  modified Barth's solution (MBS) (26) sup- 
plemented with 50/xg/mi cycloheximide and germinal vesicle and cytoplas- 
mic fractions then were manually separated.  Cytoplasmic fractions were 
homogenized in 0.02% Triton X-100, centrifuged at 10,000 g for 1 rain and 
supernatant was collected and combined with 4 vol of ethanol and held at 
-70oc for 30 min to precipitate proteins.  Proteins from germinal vesicle 
fractions were directly precipitated with 4 vol of ethanol at -70~  Proteins 
were resuspended in Laemmii sample buffer (23), boiled for 5 rain and 1.5 
oocyte equivalents were loaded onto 10% SDS-polyacrylamide gels. After 
electrophoresis,  gels were fixed,  enhanced (EnHance, Amersham Corp., 
Arlington Heights,  IL), dried and exposed to x-ray film for 3-7 d. Bands 
on the autoradiographs were then scanned and quantitated densitometri- 
cally. 
Injections and lmmunofluorescence 
Fertilized, dejellied eggs were injected with ,~5 his (0.1 ltg//zl) of either 
pCE, which codes for the wt Ela protein, or pCER, which encodes a trun- 
cated protein that lack the carboxy-terminal 66 residues  and, hence, the 
COOH-terminal NLS. Embryos were maintained in 5% Ficoll, 0.1x MBS 
until gastrulation then transferred to 0.1x MBS. They were allowed to de- 
velop until the stages indicated in the Figures and then fixed in 4% parafor- 
maidehyde,  0.1x  MBS, pH 7.5, for 12 h at 4~  and prepared for paraffin 
histology. Alternatively,  some fixed embryos were embedded in plastic ac- 
cording to the manufacturers directions (Immunobed, Polysciences,  War- 
rington, PA). Wax sections were taken at 8-10 tim and plastic sections were 
taken at 5/~m. Sections were blocked against nonspecific binding using 5 % 
BSA in TBS, pH 7.5, and immunostaining used either monoclonal (M73) 
or rabbit anti-serum diluted into blocking solution at ratios of 1:100-1:500. 
Appropriate fluoresceinated  secondary antibodies were applied at 1:500 di- 
lution. Hoechst dye (0.05 #g/ml) was used as a nuclear stain. Embryos were 
staged according to Nieuwkoop  and Faber (37). 
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To study specifically  the NLS activity of Ela residues 140-185, fusion pro- 
teins were constructed that placed these residues at the carboxy terminus 
of the maltose binding protein (MBP) using the procedures and materials 
described in the pMAL kit (New England Biolabs, Beverly, MA). For inser- 
tion into the pMAL-c vector, an EcoRI restriction endonuclease site was 
placed at nucleotide 968 in the pCER plasmid using site-directed mutagene- 
sis as described above with the oligonucleotide-  CTCCTCACCGAA'I"I'C- 
ATCCTCGTC.  This construct, pCER-845,  was then digested with EcoRI 
and HincII to release a 604 nucleotide fragment that was inserted into the 
pMAL-c vector which had been digested with XbaI, filled in with Klenow 
and then digested  with EcoRI.  The resulting  fusion protein (14085-MBP) 
contains Ela residues 140-185 at the carboxy terminus of the MBP. A trans- 
lational stop codon (TGA) is positioned two codons downstream of Ela 13S 
codon 185 so that the fusion protein would contain Ela residues 140-185 
plus an additional lysine at the carboxy terminus. An additional fusion pro- 
tein was also constructed by cleaving the pSP12S clone with XbaI and Hin- 
dIII and ligating this fragment into the pMAL-c vector that had also been 
digested  with Xbal and  HindIII.  This clone produces  a  fusion protein 
(CNLS-MBP) that includes the carboxy-terminal 66 residues of Ela and, 
therefore, contains the carboxy-terminal NLS. Purified fusion proteins were 
concentrated and buffers were exchanged using Centricon 30 microconcen- 
trators (Amicon, Beverly, MA). 
For use in rate determinations, 5 nl of a 20 #g/#l solution of fusion pro- 
teins in TBS were injected into oocytes,  groups of three were taken at the 
times indicated and cytoplasms and germinal vesicles were manually sepa- 
rated. Cytoplasms were homogenized in 0.2% Triton X-100, centrifuged at 
10,000 g for 3 min, supernatants were collected, combined with 4 vol of 
ethanol and placed at -70~  for 30 min to precipitate proteins.  Germinal 
vesicle fraction proteins were precipitated directly with 4 vol of ethanol and 
incubation at  -70"C.  Proteins from both fractions were  resuspended in 
sample buffer and, typically 0.5 oocyte equivalents  were resolved on 10% 
SDS-polyacrylamide gels. Proteins were then transferred to nitrocellulose 
which was then blocked for nonspecific binding with 5% dried milk in 200 
mM NaCI,  20 mM Tris, pH 7.5, 0.1% Tween-20,  for 1 h and probed with 
anti-MBP antibodies (New England Biolabs) diluted 1:10,000 into blocking 
buffer. The blots were washed in 200 mM NaC1, 20 mM Tris, 0.1% Tween- 
20,  which  was  followed  by  the  applicatio n  of a  HRP-conjugated  goat 
anti-rabbit  secondary  antibody  (Vector  Labs,  Inc.,  Burlingame,  CA) 
diluted 1:5,000 into blocking buffer. Blots were washed extensively, devel- 
oped using enhanced chemiluminescence (ECL, Amersham Corp.) and ex- 
posed to x-ray film. Resulting images were quantitated densitometricaUy. 
For competition studies, we first determined that the intraoocyte concen- 
tration of the CNLS-MBP fusion protein that could effectively compete 
with the Ela 12S protein without increasing oocyte mortality was •25-30 
/zM (,u30 nl of a 20 #g/#l solution injected assuming a 50-kD protein and 
0.5 ttl yolk-free volume in the oocyte).  All proteins were made to 20 #g/ul 
in TBS and 30 nl of each were injected into oocytes,  which were then in- 
cubated  in  lx  MBS  for  1  h.  30  nl  of reticulocyte  lysate  containing 
[35S]methionine-labeled  Ela  12S protein were  then injected and oocytes 
were held in lx MBS supplemented with 50 t~g/ml cycloheximide. At indi- 
cated times groups of three oocytes were collected, cytoplasmic and germi- 
nal vesicles manually separated,  and then prepared as above for ATP deple- 
tion studies.  Protein concentrations were  made using the Bradford assay 
with BSA as the standard. 
Results 
General Characterization of  Ela Nuclear 
Localization Signals 
Using injected Xenopus  oocytes, Slavicek et al.  (59), local- 
ized an Ela NLS to residues 140-185. To confirm and extend 
these data, we injected DNAs or mRNAs encoding wild-type 
Figure 1. The 289-residue Ela protein contains two nuclear localization signals. DNAs (pCE and pCER) and RNAs (pSP12S and pSP12SX) 
encoding wild-type or mutant Ela proteins were injected into oocytes that were then incubated with [35S]methionine. Cytoplasms (CYTO) 
and nuclei (germinal vesicles or GV) were manually separated and Ela proteins were then immunoselected from each fraction and analyzed 
with SDS-PAGE and autoradiography.  The distribution of the Ela wild type,  ElaX (lacking residues 222-289),  Elal2S (SP12S:  lacking 
residues  140-185),  and  12SX protein (SP12SX:  lacking residues  140-185  and 222-289)  were based on quantitative densitometry.  The 
amount nuclear for all proteins in Figs.  1-4 is expressed as a percentage of the amount nuclear for the ElaX protein, which was determined 
empirically within each experiment. The relative values are expressed symbolically as:  +, 90-100 % of +/-,  30-90 % of ElaX;  -,  <30 % 
of ElaX. 
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terization  of the  Ela second 
NLS.  (a)  Typical profile for 
nuclear  accumulation  of re- 
ticulocyte  lysate-synthesized 
[35  S]methionine-labeled, EIaX 
(A),  12S (o), and  12SX (m) 
proteins in oocytes after cyto- 
plasmic  injection.  (b)  Time 
course for nuclear accumula- 
tion of  fusions  proteins; 14085- 
MBP  (A),  CNLS-MBP  (a), 
and MBP (e) after cytoplas- 
mic  injection.  Proteins were 
detected by Western blotting 
using anti-MBP antibodies. (c) 
In vivo ATP depletion by apy- 
rase enzyme inhibits the nu- 
clear  accumulation  of EIaX 
and  12S proteins.  A graphic 
representation of the distribu- 
tion of the 12S and ElaX pro- 
teins in the presence ([]12S + 
Apyrase; ~ElaX  +  Apyrase) 
or absence (,,12S; elElaX) of 
the  apyrase enzyme (0.3 U/ 
oocyte) at  1 or 2 h after in- 
jection  of  [35S]methionine- 
labeled,  reticulocyte  lysate 
generated proteins. (d) Com- 
petition  studies between the 
Ela  carboxy  terminus  NLS 
and  drNLS  for nuclear  im- 
port. [35S]methionine-labeled, 
reticulocyte lysate synthesized 
12S protein (n) was injected 
into the cytoplasm of oocytes 
previously injected with 0.5/~g 
of CNLS-MBP  (el), 14085- 
MBP (el), or MBP ([]). After 
incubation,  the  amount  of 
labeled 12S protein in the nu- 
cleus was determined by SDS- 
PAGE of cytoplasmic and nu- 
clear protein, autoradiography, 
and densitometry of resulting 
bands. 
or mutant Ela proteins into oocytes, which were then radio- 
labeled with [35S]methionine.  The oocyte nuclei (germinal 
vesicle or gv) and cytoplasms were then manually separated 
and the Ela proteins in each fraction were immunoselected 
and analyzed by SDS-gel electrophoresis and autoradiogra- 
phy. Fig. 1 shows that Ela wild type, ElaX (lacking residues 
222-289) and Ela SP12S (lacking residues 140-185), were 
all predominantly nuclear (>50%) 4 h after the addition of 
label. Because Ela SP12SX (lacking residues 140-185 and 
222-289)  was  not transported to the nucleus to  any  sig- 
nificant extent, (<10% nuclear), this experiment suggests the 
presence of two NLSs in Ela, one residing between residues 
140 and 185, and one residing between residues 222 and 289. 
Finally, we note that the multiple Ela molecular weight vari- 
ants observed in Figs. 1 and 3-5 are due to differential phos- 
phorylation, which probably does not play a role in nuclear 
localization (45). 
To determine whether Ela residues 140-185 direct nuclear 
accumulation through selective import pathways or through 
"diffuse and bind" mechanisms, we first compared the rate 
of  import  of  the  signal  contained  within  Ela  residues 
140-185  with the Ela  COOH-terminal NLS,  the latter of 
which is similar to the SV-40 T-antigen NLS in structure and 
function (25). As shown in Fig. 2 a, in vitro synthesized 12S 
protein, which contains only the COOH-terminal NLS, and 
the  ElaX,  which  contains  only the  putative  NLS  within 
residues 140-185, accumulate rapidly in oocyte nuclei after 
cytoplasmic injection.  By comparison,  12SX,  which con- 
tains no nuclear localization signal, does not localize in the 
nucleus, We also note that because Ela 12S has a more rapid 
accumulation relative to  ElaX,  that protein probably con- 
tains the more effective NLS. 
Next, we have determined whether the putative Ela NLS 
residing between residues 140-185 can direct nuclear import 
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Ela  residues 140-185.  Four 
consecutive  deletions  were 
made within residues 140-185 
of the  ElaX protein  and  are 
denoted with a box. Ela pro- 
teins were detected and quan- 
titated as in Fig.  1. 
of a heterologous protein. This was necessary since the Ela 
residues 140-185 globin construct reported previously (59) 
was shown to be incorrect (D.  M.  Standiford; personal ob- 
servation). When fused to the carboxy terminus of the mal- 
tose binding protein, Ela residues  140-185  stimulated nu- 
clear import of the 50-kD chimeric protein (Fig. 2 b). For 
comparison,  we  show  that the carboxy-terminal Ela NLS 
also directs nuclear import of the maltose binding protein, 
but the maltose binding protein by itself remains predomi- 
nantly cytoplasmic (Fig.  2 b). 
An important feature of selective nuclear import is its de- 
pendence on ATP for the transport of proteins across the nu- 
clear pore (34,  35,  42).  We have tested the effects of ATP 
depletion on the second Ela signal in vivo using the apyrase 
enzyme, which has been shown to block the import of other 
karyophilic proteins both in vivo and in vitro (34, 35). When 
in vitro-synthesized 12S or ElaX proteins are injected into 
oocytes previously  injected  with  apyrase  (0.3  U/oocyte), 
both show a marked reduction in their nuclear import com- 
pared with that of nonapyrase-injected oocytes (Fig. 2 c), in- 
dicating that both signals are dependent on ATP for function. 
When effects of apyrase were tested using the CNLS- and 
14085-MBP fusion proteins, both were also found to be in- 
hibited for nuclear import (not shown). 
It has been shown recently that a number of different nu- 
clear targeting pathways exist in the cell (13, 28) and that 
macromolecules using these pathways do not compete with 
each other for import. For instance the m3GpppN-Sm pro- 
tein containing UsnRNPs do not compete with T-antigen- 
like NLSs for import (27). To determine whether the two Ela 
NLSs operate using like or different import pathways, com- 
petition studies were performed by challenging the radiola- 
beled reticulocyte lysate synthesized 12S protein for nuclear 
import with either the CNLS-MBP,  14085-MBP,  or MBP 
proteins (Fig.  2 d).  From these experiments, it was found 
that the nuclear accumulation of  the 12S protein is effectively 
reduced by the presence of both the 14085-MBP and CNLS- 
MBP protein, but is not affected by the maltose binding pro- 
tein alone, indicating that the two signals are using similar 
components of the nuclear import pathway.  The increase in 
import of the 12S protein in the presence of MBP is likely 
due  to  experimental  variation.  Interestingly,  the  CNLS- 
MBP appears to be a  better competitor than does  14085- 
MBP which may be related to the observation that the Ela 
COOH terminus NLS is the more effective NLS. 
Determination of the drNLS Primary Structure 
To begin defining the exact residues that comprise the inter- 
nal NLS, a series of deletion mutations through the 140-185 
domain  was  used.  Fig.  3  shows  that  deletion  mutant 
DLlll0X, which lacks residues 140-160 in the internal do- 
main,  was  reduced in the nucleus by 20-30%  relative to 
ElaX after 4 h of radiolabeling. Deletion of residues 161-168 
(DLIll2X)  had  no  effect  on  nuclear  transport,  but  the 
removal of residues 169-177 (DL1113X) had a severe effect 
on transport, reducing the amount of Ela in the nucleus by 
75 %  compared with ElaX.  The final deletion of residues 
178-184  (DLlll4X)  also  reduced  transport,  but  only by 
20-30%  relative to  ElaX.  These data  show that  residues 
169-177 are critical for nuclear import, but also that residues 
140-160 and 177-184 have some influence on nuclear local- 
ization. 
To identify the precise nuclear localizing residues defined 
by mutant DL1113X, a further series of mutations was con- 
structed (Fig. 4). The mutant Ela protein encoded by p308 
substitutes  ala.tyr  for met~7~  and  deletes  ser~72-met  ~76. 
When tested for nuclear localization in oocytes as described 
above, this protein was found to be <25 % nuclear after 4 h, 
showing that Ela residues met~7~  ~76 are important com- 
ponents of the NLS. Inspection of residues 170-176 reveals 
the presence of two cysteine residues that have been shown 
previously to participate in a  zinc finger structure (5).  To 
ascertain if this cysteine-mediated structure was important 
for drNLS function,  cys  17l  was  substituted  with histidine, 
pH171,  or both cys  ~7~ and cys  TM  were substituted with phe- 
nylalanine, pF2. Neither of these substitutions had any effect 
on transport indicating that the zinc finger is not important 
for signal function. 
Further pair-wise amino acid substitutions were then made 
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ysis of Ela residues  169-177. 
Plasmids  encoding  Ela  pro- 
teins with amino acid substi- 
tutions  (boM) or  a  deletion 
(boxed)  were  injected  into 
oocytes,  followed by  radio- 
labeling  with  [3SS]methio- 
nine. The detection of Ela in 
nuclei and cytoplasms and the 
calculation  of  their  relative 
amounts in the nuclei, were as 
described in Fig.  1. 
through residues 169-176, replacing the wild-type residues 
with  glu.phe.  Each of these mutations;  p848  (ile~7~  --" 
glu.phe),  p846  (sermleu~glu.phe),  and p847  (tyrt75met  ~ 
glu.phe), resulted in the reduction of nuclear transport. The 
mutation in p848, however, was found to have the strongest 
effect, reducing transport by >60% relative to ElaX. These 
data show that Ela residues met*7~  are 
important for signal function. 
As  shown  in  Fig.  3,  the  removal  of residues  140-160 
(DL1110X) or 178-184 (DL1114X) reduced nuclear localiza- 
tion of Ela. To further explore these regions and their effects 
on transport, an additional set of  mutations were constructed 
and are shown in Fig.  5. 
To determine which amino acids among residues 178-185 
are  important  for  transport,  met*8~.phe were  substituted 
with lys.leu by the placement of a HindlII restriction site in 
the coding sequence, pH 3. These substitutions reduced Ela 
transport by ~30%  compared with ElaX, which is similar 
to that caused by the entire deletion in DLllI4X (Fig.  3). 
Thus met~St.phe comprise a portion of this Ela NLS. 
Residues in the 140-160 region were first examined with 
the  pA20  deletion,  which  removes  Ela  residues  150-170 
(Fig. 5). This mutant was found to be equal to that of ElaX 
in  its  nuclear/cytoplasmic distribution  (>50%),  indicating 
that  these  residues  are  not  important  for transport.  Two 
further  deletions  of  leW44-his  l~~ (p4157)  and  phe14e-his  ~~ 
(p4153) were then constructed and when tested in oocytes, 
were found to have different effects on nuclear localization. 
The protein encoded by p4157 retained ElaX levels of nu- 
clear transport, whereas the protein encoded by p4153 was 
reduced in the nucleus by ~30%  relative to ElaX.  These 
results show that phe  ~42.val are important for signal function. 
Next we combined the amino acid deletions of p4153 and 
p4157 with the met  TM.phe represented in the pH 3 substitu- 
tion (p4153-H3 and p4157-H3, respectively) (Fig.  5).  The 
protein encoded by the p4157-H3 was reduced in nuclear lo- 
calization by ~30% compared with ElaX. Nuclear transport 
of the protein encoded by p4153-H3, on the other hand, was 
essentially eliminated. Taken together, the above data dem- 
onstrate  that  the  second  Ela  NLS  has  the  structure 
phe.val(x)7-20.met.x.ser.leu.x.tyr.-met.(x)4.met.phe. 
Analysis of Ela Nuclear Localization During 
Xenopus Embryogenesis 
Slavicek et al. (59) have shown that an Ela containing only 
Figure 5.  Identification of a 
minimal  Ela  NLS.  Plasmids 
encoding proteins containing 
amino acid substitutions (bold) 
or deletions (boxed) were in- 
jected into oocytes.  The de- 
tection  and  quantification of 
Ela in nuclei were as described 
in Fig.  1. 
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tions during the late gastrula stage 
of  development.  Fertilized eggs 
were injected with DNA coding for 
the  wild-type Ela  (pCE), which 
contains both Ela NLSs, or DNA 
coding for a truncated Ela (pCER), 
which contains only the NLS lo- 
cated within residues 140-185 (the 
drNLS).  The  embryos  were al- 
lowed to develop to the late gas- 
trula stage when they were fixed, 
embedded  in  plastic resin, sec- 
tioned, and stained for Ela protein 
using anti-Ela antibodies or DNA 
using Hoechst dye. a and b show a 
section of the  dorsal region of a 
pCE injected embryo stained with 
anti-Ela antibodies or Hoechst, re- 
spectively. Arrowheads denote nu- 
clei that did not stain for Ela be- 
cause of mosaicism, c and d show 
a section of the dorsal region of a 
pCER-injected embryo stained with 
anti-Ela antibodies or Hoechst, re- 
spectively,  e  shows an uninjected 
late gastrula stage embryo treated 
with  anti-Ela antibodies.  Bars, 
25/zm. 
the  NLS  located between  residues  140  and  185  becomes 
localized in nuclei of  injected Xenopus  oocytes, but not trans- 
fected Xenopus A6 cells or Hela cells.  This might suggest 
that the function of this NLS is regulated during Xenopus de- 
velopment. To determine whether this is the case, DNAs en- 
coding wild-type or a carboxy-truncated Ela (ElaX) were in- 
jected into fertilized Xenopus eggs, which were then allowed 
to develop into embryos of  various stages. The embryos were 
fixed, embedded, sectioned, and reacted with Ela antibodies 
and fluorescein-conjugated secondary antibodies. 
Fig.  6 shows the pattern of nuclear localization of these 
proteins in late gastrula stage embryos, a and b show immu- 
nostaining and DNA staining (Hoechst's dye) of the dorsal 
part  of a  sectioned  embryo injected  with  pCE  (encoding 
wild-type Ela). While not all cells show immunostaining due 
to mosaicism (arrowheads),  those cells that do react with Ela 
antibody show fluorescence over nuclei. Similarly,  the trun- 
cated protein encoded by pCER (ElaX) shows nuclear local- 
ization (compare c and d). e demonstrates a lack of fluores- 
cence when noninjected embryos were treated with the same 
antibodies as in a  and c. 
Sections from a pCER injected embryo taken at the early 
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functions during the early neu- 
rula stage of development. Fer- 
tilized eggs were injected with 
pCER, allowed to develop until 
the  early  neurula  stage, em- 
bedded  in paraffin,  sectioned, 
and stained with either anti-Ela 
antibodies  (a  and  c)  or  with 
Hoeehst (b and d). In a and b is 
a low magnification view of a 
section  through an embryo show- 
ing  various  embryonic  tissues 
while  c  and d  show a  higher 
magnification of the notochord 
and surrounding tissues. ARC, 
archentron; ENDO, endoderm; 
ME, mesoderm; NO, notochord. 
Bars: (b) 50/~m;  (d) 25/~m. 
neurula stage of development are shown in Fig. 7. In this em- 
bryo, the ElaX protein is still localized to the nuclei of cells 
throughout (compare a  and b). This is particularly evident 
in the notochord (c and d). By the mid-neurula stage, how- 
ever, the ability of the embryo to localize ElaX protein to the 
nucleus is beginning to abate. Fig.  8 shows  an embryo in- 
jected with pCE in which the wild-type Ela protein continues 
to localize to the nuclei of ceils in all rnid-neurula stage tis- 
sues (a and b). At this same stage in embryos injected with 
pCER, however, the truncated ElaX protein has become pri- 
marily cytoplasmic in the notochord, mesoderm, and neural 
ectoderm, while remaining nuclear in other tissues such as 
endoderm (c and d). This difference is most evident under 
closer inspection of the notochord. While wild-type Ela is 
clearly nuclear in this tissue (e and f), the truncated ElaX 
protein is cytoplasmic (g and h). Therefore, the ability of Ela 
to be localized to the nucleus via the residues within 140-185 
changes during mid-neurulation. 
By the late neurula stage, ElaX is cytoplasmic in all tissues 
except for the epidermal ectoderm (Fig. 9, a-d). In tailbud 
stage embryos, ElaX protein is now cytoplasmic in all tissues 
including epidermal ectoderm (e and f). For comparison, a 
tailbud stage embryo that is expressing wild-type Ela con- 
tinues to localize the protein to the nuclei of cells (compare 
g and h). We also show that noninjected embryos taken at 
the  tailbud  stage  do  not  offer a  fluorescent signal  when 
reacted with the same antibodies as in Fig.  8 e. 
The data in Figs. 5-8 show that ElaX localizes to the nu- 
cleus until the neurula stage of development. Because the 
sole NLS in this protein is that which we have defined as the 
residues within residues 140-185, we now define this signal 
as the Ela developmentally regulated NLS (drNLS). 
Discussion 
We have presented evidence to show that the adenovirus Ela 
protein contains two NLSs. The first signal is located at the 
Ela carboxy terminus and corresponds to the pentapeptide 
KRPRP, which was identified initially by Lyons et al. (25). 
This sequence, which is reminiscent of many other NLSs in 
that it is a short peptide composed of  basic residues, acts con- 
stitutively to direct nuclear import in several cell lines as 
well as in injected Xenopus oocytes (25, 59; see also Fig. 1). 
The second Ela NLS resides internally in the protein and is 
composed of the sequence FVXv_20MXSLXYMX4ME  This 
sequence directs nuclear localization only in oocytes and 
early embryos; hence, it is referred to as the Ela drNLS. 
Because the drNLS is located in a small protein (35 kD) 
that could potentially diffuse into the nucleus and bind pref- 
erentially to some nuclear component via the drNLS, we 
performed several experiments to test whether the import 
and accumulation of the ElaX protein is through a diffuse 
and bind pathway, or through selective import pathways.  We 
first showed that the drNLS can efficiently direct the nuclear 
import of a large (50 kD) fusion protein (14085-MBP; Fig. 
2 c) to the nucleus and does so with kinetics approximating 
that of the ElaX protein (26 kD), suggesting that import of 
ElaX and  14085-MBP is NLS dependent. We should note 
that a previous report showed that the Ela residues 1-120 also 
accumulated in the oocyte nucleus after a  24-h incubation 
The Journal of Cell Biology, Volume 118,  1992  998 Figure 8. The activity of the second Ela NLS begins to abate during neurulation. Fertilized eggs, injected with either the pCE (a, b and 
e,f) or pCER (c, d and g, h) DNAs were allowed to develop until the mid-neurula stage, then fixed, embedded in paraffin, sectioned, 
and stained with anti-Ela antibodies (a, c, e, and g) or Hoechst (b, d, f, and h). Low magnification views in a-d show the distribution 
of Ela proteins in various tissues, while at a higher magnification (e-h), the distribution of proteins in notochord and surrounding tissues 
can be compared. Arrowheads in g indicate continued nuclear staining of Ela in endodermal and epidermal ectoderm. ENDO, endoderm; 
EPI, epidermal ectoderm; ME, mesoderm; NF, neural fold; NO, notochord. Bars: (b) 75 #m; (d) 25/~m. 
(44). Given the small size of this peptide, we attribute this 
to diffusion, although it is unclear why it was retained in the 
nucleus. 
It has been shown by several investigators that the NLS- 
directed movement of proteins across the nuclear pore is an 
energy-dependent process (4, 34-36).  The injection of the 
apyrase enzyme into oocytes, shown to reduce ATP and nu- 
clear transport both in vivo and in vitro (35), was found to 
reduce nuclear import for both the Ela carboxy terminus and 
drNLSs (Fig. 2 c). In addition, we find that both the 12S and 
ElaX proteins are excluded from the nucleus when oocytes 
were incubated at 0~  (not shown). This latter observation 
also suggests the presence of an NLS within Ela residues 
140-185 because Breeuwer and Goldfarb (4) have found that 
small proteins that do not contain an NLS freely diffuse into 
nuclei, while small NLS-containing proteins are retained in 
the cytoplasm of chilled cells. 
The existence of several distinct nuclear targeting path- 
ways has recently been recognized (13, 27, 28). We have be- 
gun to identify the pathway used by the drNLS for nuclear 
import by examining its ability to compete with the Ela car- 
boxy terminus NLS (a large T-antigen-like NLS). When the 
nuclear import of the  12S protein was challenged with the 
drNLS- and CNLS-MBP fusion proteins, it was found that 
both could efficiently compete for nuclear import (Fig. 2 d), 
while MBP had no effect. These data indicate that the two 
signals  use  similar  components  of  the  nuclear  import 
pathway. 
Mechanisms of Nuclear Localization 
There are  several  models  through  which the  Ela drNLS 
might direct nuclear localization. First, the drNLS could act 
by binding directly to a NLS-receptor protein similar to that 
used by the SV-40 large T-antigen-like NLSs (1, 61), and thus 
would use the same  nuclear import mechanisms as  these 
NLSs (56). However, because drNLS function is regulated 
during development, one would have to imagine that there 
are several isotypes of the NLS receptor protein available 
and that the particular receptor protein bound to the drNLS 
is itself developmentally regulated, or that the drNLS is "an- 
chored" in the cytoplasm during development by additional 
proteins not present in the oocyte. A  second possibility is 
that the drNLS binds to a soluble protein that itself contains 
a  T-antigen-like NLS,  thus  promoting the  import of the 
drNLS via a piggy-back mechanism; a situation that has been 
observed elsewhere (3).  This model could account for the 
developmental regulation of drNLS-mediated nuclear im- 
port if the NLS-containing protein is itself present in a de- 
velopmentally regulated fashion. However, the observation 
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tissues at the end of  neurulation. Embr3~s injected 
with pCER were allowed to develop until the late 
neurula (a-d) or tailbud (e and  f) stage of  develop- 
ment,  then prepared  as described  in Fig. 7. In a 
and b is a low magnification view of an embryo 
stained  with anti-Ela antibodies  or Hoechst,  re- 
spectively, showing the distribution  of the trun- 
cated Ela across the embryo, c and d show a higher 
magnification view of  the dorsal region of  the same 
embryo. A pCER injected embryo allowed to de- 
velop until the tailbud stage before sectioning and 
staining with anti-Ela or Hoechst is shown in e and 
f, respectively. In g and h is a pCE-injected embryo 
at the tailbud stage of development stained with ei- 
ther anti-Ela or Hoechst, respectively, and in i, a 
noninjected tailbud stage embryo stained for Ela 
is shown. ENDO, endoderm; EPI,  epidermal ecto- 
derm; ME, mesoderm; NO, notochord.  Bars:  (b 
and h) 75 #m; (d and f) 30 #m. 
that the 14085-MBP protein can compete with the 12S pro- 
tein for nuclear import would suggest that the pool of drNLS 
binding proteins is large and that import does not occur in 
the absence of drNLS binding. A third possibility is that the 
drNLS might have affinity for some component of the trans- 
port machinery found at the nuclear pore complex, such as 
a  pore receptor that  serves to  recognize  the  cytoplasmic 
NLS-receptor protein. 
Distinctive Features of the drNLS 
If it is the case that the Ela drNLS represents a new type of 
nuclear localization signal, then two features distinguish it 
from  other  known  NLSs.  First,  functionally  important 
amino acids are separated by apparently nonspecific spacer 
residues. While complex NLSs with this general character 
have been described previously (reviewed in 56),  they usu- 
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by nonspecific spacer  residues  (48).  In contrast,  the  Ela 
drNLS is composed of three distinct groups that are sepa- 
rated by spacer residues. 
The second distinctive feature of the Ela drNLS is that it 
is remarkably hydrophobic; indeed, five of seven important 
residues are classified as such. This might suggest that the 
activity of the drNLS depends upon its ability to interact 
hydrophobically with other proteins. These types of interac- 
tions seem important and would perhaps account for the ob- 
served context dependency of the drNLS for function, a fea- 
ture influencing the behavior of various other NLSs (15, 33, 
63).  This was  implied when a  minimal drNLS  sequence 
represented by the A20 protein (Fig. 5) was placed before 
the Xenopus B-globin  protein where it functioned very in- 
efficiently (not shown).  Because of its wild-type levels of 
transport in the Ela background, the minimal drNLS could 
require a certain number of flanking residues, likely of hy- 
drophobic character, for it to function efficiently. 
Assessment of  an Ela drNLS-like Sequence 
in Other Proteins 
We have searched the entire SwissProt data base for proteins 
with sequences  similar to the Ela drNLS using the GCG 
Findpatterns program (7).  Because we have not determined 
all the parameters of spacing between the drNLS functional 
groups, we conducted the search using the somewhat broad- 
ened search sequence FVX~_3oMXSLXYMXI.~0MF and al- 
lowed for up to three mismatches. Among the more than 
2  x  10'  protein  sequences  searched  many contained se- 
quences similar to the Ela drNLS. Several of these were nu- 
clear proteins, perhaps the most intriguing of which was that 
of the glucocorticoid receptor from rat, mouse, and human. 
The rat receptor (29) contains the sequence- asa4V(x)17Mxl  - 
LxYsxME  (residues  matching the  drNLS are  in capital); 
similar sequences also exist in the mouse (6) and human (17) 
receptor proteins as well. Interestingly, this sequence lies 
within the steroid binding domain of the receptor, which is 
also the region shown to contain an as yet undefined NLS 
that is regulated through the binding of steroid hormone (32, 
40).  It is possible that this sequence is the glucocorticoid 
receptor hormone-regulated NLS. 
The Ela drNLS Functions Only during 
Early Development 
We have demonstrated that the Ela drNLS directs nuclear 
import  in  a  temporal  and  tissue-specific  manner  during 
Xenopus embryogenesis. Fig. 6  shows that an Ela protein 
truncated at residue 222, whose sole NLS is that which we 
have defined as the drNLS, directs nuclear import in gastrula 
stage cells.  While the truncated protein continues to ac- 
cumulate in the nucleus in the early neurula before the for- 
mation of the neural tissues (Fig. 7 c), by the mid-neurula 
stage when neural ectoderm is well developed, the drNLS 
is nonfunctional in notochord, mesoderm and neural ecto- 
derm  as  evidenced by clear cytoplasmic immunostaining 
(Fig. 8, g and h). Importantly, full length Ela, which carries 
the constitutive carboxy-terminal NLS as well as the drNLS, 
is  nuclear at this  same  stage  (Fig.  8,  e  and f).  At late- 
neurula, the truncated Ela has become cytoplasmic in loca- 
tion everywhere but in the epidermal ectoderm (Fig. 9, a-d) 
and the drNLS is completely nonfunctional in the embryo in 
tailbud stage embryos (Fig. 9, e and f). 
We believe that cellular proteins contain drNLSs that are 
similar in structure too that which is fortuitously present in 
Ela. Moreover, it is not unreasonable to suspect that normal 
development  depends  upon  cellular  proteins  whose  nu- 
clear/cytoplasmic distribution changes in a manner similar 
to that displayed by ElaX. Thus, it is possible that the redis- 
tribution of a protein from nucleus to cytoplasm could have 
important consequences for neurulation. Clearly, regulated 
nuclear transport controls developmental events in Drosoph- 
i/a (see introduction) and possibly in Xenopus  as well. For ex- 
ample, fibroblast growth factors (FGFs), which are thought 
to be important for mesoderm induction in Xenopus (58), 
have been shown by Shibura et al. (55) to be positioned in 
the cytoplasm until the blastula stage. At this point, which 
coincides with the start of mesoderm induction (21), FGF re- 
localizes to the cell nucleus. Whether this time-dependent 
nuclear localization of FGF is critical for mesoderm induc- 
tion is unclear, but the provocative nature of these results 
suggest that it could. Given this example and the large num- 
ber of additional proteins whose cellular location shifts dur- 
ing Xenopus development (8, 9, 30, 65), it seems that regu- 
lated nuclear import could potentially be a major mechanism 
controlling certain developmental events. 
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